Literature DB >> 25268941

Brain metastasis of crystal-deficient, CD68-positive alveolar soft part sarcoma: ultrastructural features and differential diagnosis.

Matthew D Cykowski1, John Hicks, David I Sandberg, Adriana Olar, Julia A Bridge, Patricia T Greipp, Patricia Navarro, Steven Kolodziej, Meenakshi B Bhattacharjee.   

Abstract

We report a case of alveolar soft part sarcoma (ASPS) presenting as an isolated frontal lobe metastasis. The tumor demonstrated little or no immunoreactivity for a broad panel of antibodies yet strong, diffuse immunoreactivity with CD68. On electron microscopy, the characteristic rectangular to rhomboid crystalline inclusions of ASPS were not present. Electron-dense granules resembling peroxisomes were present, sometimes in association with elongated granular structures having a periodic, lattice-like arrangement. Metastatic ASPS was confirmed by demonstration of an ASPSCR1-TFE3 fusion and imaging studies that excluded metastatic Xp11.2 translocation renal cell carcinoma. The primary site was subsequently identified in the lower extremity.

Entities:  

Keywords:  Alveolar soft part sarcoma; CD68; brain metastasis

Mesh:

Substances:

Year:  2014        PMID: 25268941      PMCID: PMC4308420          DOI: 10.3109/01913123.2014.950778

Source DB:  PubMed          Journal:  Ultrastruct Pathol        ISSN: 0191-3123            Impact factor:   1.094


  24 in total

Review 1.  Chromosome rearrangement at 17q25 and xp11.2 in alveolar soft-part sarcoma: A case report and review of the literature.

Authors:  S Joyama; T Ueda; K Shimizu; I Kudawara; M Mano; H Funai; K Takemura; H Yoshikawa
Journal:  Cancer       Date:  1999-10-01       Impact factor: 6.860

2.  A distinctive subset of PEComas harbors TFE3 gene fusions.

Authors:  Pedram Argani; Sebastian Aulmann; Peter B Illei; George J Netto; Jae Ro; Hyun-yee Cho; Snjezana Dogan; Marc Ladanyi; Guido Martignoni; John R Goldblum; Sharon W Weiss
Journal:  Am J Surg Pathol       Date:  2010-10       Impact factor: 6.394

3.  Primary alveolar soft part sarcoma arising from the cerebellopontine angle.

Authors:  Sook Hyon Ahn; Ji Yeoun Lee; Kyu-Chang Wang; Sung-Hye Park; Jung-Eun Cheon; Ji Hoon Phi; Seung-Ki Kim
Journal:  Childs Nerv Syst       Date:  2013-06-22       Impact factor: 1.475

Review 4.  Alveolar soft part sarcoma: a review and update.

Authors:  N G Ordóñez
Journal:  Adv Anat Pathol       Date:  1999-05       Impact factor: 3.875

5.  The precrystalline cytoplasmic granules of alveolar soft part sarcoma contain monocarboxylate transporter 1 and CD147.

Authors:  Marc Ladanyi; Cristina R Antonescu; Marija Drobnjak; Ann Baren; Man Yee Lui; David W Golde; Carlos Cordon-Cardo
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

Review 6.  Alveolar soft-part sarcoma: a review and update.

Authors:  A L Folpe; A T Deyrup
Journal:  J Clin Pathol       Date:  2006-11       Impact factor: 3.411

7.  Surgical management of metastatic sarcoma to the brain.

Authors:  Benjamin D Fox; Akash Patel; Dima Suki; Ganesh Rao
Journal:  J Neurosurg       Date:  2009-01       Impact factor: 5.115

8.  Crystal-deficient alveolar soft part sarcoma.

Authors:  J A Tucker
Journal:  Ultrastruct Pathol       Date:  1993 May-Aug       Impact factor: 1.094

9.  Imaging features of primary and metastatic alveolar soft part sarcoma: single institute experience in 25 patients.

Authors:  S Sood; A D Baheti; A B Shinagare; J P Jagannathan; J L Hornick; N H Ramaiya; S H Tirumani
Journal:  Br J Radiol       Date:  2014-02-17       Impact factor: 3.039

10.  Rapidly progressing renal cell carcinoma associated with Xp11.2 translocations: a case report.

Authors:  Akihiro Morii; Yasuyoshi Fujiuchi; Kazuhiro Nomoto; Akira Komiya; Hideki Fuse
Journal:  J Med Case Rep       Date:  2012-06-27
View more
  1 in total

1.  Exploring the Histogenesis and Diagnostic Strategy Using Immunoassay and RT-PCR in Alveolar Soft Part Sarcoma.

Authors:  Xinxin Ju; Kunming Sun; Ruixue Liu; Shugang Li; Gulinaer Abulajiang; Hong Zou; Jiaojiao Lan; Yan Ren; Jinfang Jiang; Weihua Liang; Lijuan Pang; Feng Li
Journal:  Pathol Oncol Res       Date:  2017-08-01       Impact factor: 3.201

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.